Architects of Aesthetics

Designed to deliver volume and structure.

Aging and rapid weight loss can deplete fat and muscle. This can have an affect on the extracellular matrix (ECM), weakening the scaffold that helps support volume, structure and tissue integrity. Over time, that fragmented foundational structure is no longer able to provide the same structural quality or regenerative conditions it once did.

This is the unmet need CXU is poised to address.

OVERVIEW HOW IT WORKS KEY FEATURES

Overview

The CXU device candidate is being developed as a next-generation injectable matrix for tissue regeneration, designed to move beyond collagen alone and more closely mimic the complexity of the body’s native extracellular matrix. Unlike static fillers that simply occupy space or stimulating fillers that depend on inflammation, this collagen-based ECM device is designed to deliver the structural foundation tissue needs to regenerate, providing immediate volumizing support while helping promote longer-term correction and native tissue in-growth.

CAUTION: CXU™ is a medical device candidate in preclinical development and is not cleared or approved for marketing in the United States or any other jurisdiction.

How CXU Works

How it works

The CXU formula creates a permissive and adaptive extracellular matrix environment, designed to flow, integrate and regenerate.^9,3,6

Flow

Immediately restores lost volume
Allows for native tissue ingrowth
Slowly degraded by the body’s natural processes to leave behind native tissue

Integrate

Gels near body temperature
Forms within approximately 10 minutes
Stays in place without migration

Regenerate

Designed to mimic natural and tissue ECM
Supports native tissue restoration

CAUTION: CXU™ is a medical device candidate in preclinical development and is not cleared or approved for marketing in the United States or any other jurisdiction.

Key Features

When tissue is degraded by age, exposure to environmental factors, or aggressive weight loss, CXU is designed to deliver these benefits.^{*, 9,10,11}

Precise Conformability

Flowable and injectable for precise placement via a fine-gauge needle, conforming to varied tissue environments.

Low Inflammatory Profile

Designed to promote constructive tissue response with minimal inflammation.

Biomimetic Support

Designed to mimic key properties of native extracellular matrix and support native tissue in-growth.

*Design intent based on preclinical evidence. These findings were generated in controlled laboratory settings and animal models. Animal physiology differs from human physiology and these findings may not be predictive of clinical performance or safety in humans. Clinical significance not yet established.

IMPORTANT NOTICES: CXU™ is a medical device candidate in preclinical development. It has not been submitted to or reviewed by the U.S. Food and Drug Administration. Safety and effectiveness have not been established. See Forward-Looking Cautionary Statement.Terms such as 'next-generation,' 'advanced,' 'innovative,' and 'bioregenerative' reflect the Company's assessment of its technology relative to existing approaches and are not intended as representations of regulatory status, clinical performance, or guaranteed commercial outcomes. CXU™ is an investigational medical device candidate. Safety and effectiveness have not been established. See Forward-Looking Cautionary Statement.

Architects of Aesthetics

Overview

How it works

Key Features

Explore Other Applications

Wound Care

Aesthetics

Oral Health

Animal Health

3-D Tissue

Contact Us

OUR PLATFORM | APPLICATIONS

Architects of Aesthetics

Overview

How it works

Key Features

Explore Other Applications

Wound Care

Aesthetics

Oral Health

Animal Health

3-D Tissue

Contact Us

Error Displaying Name

Error Displaying Title